<DOC>
	<DOC>NCT01734902</DOC>
	<brief_summary>The objective of the current trial is to establish the bioequivalence of 2 hyoscine butylbromide dose forms following oral administration.</brief_summary>
	<brief_title>Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Inclusion criteria: 1. Healthy male and female subjects Exclusion criteria: 1. Any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>